15 during this last 52-week period. 51. SPDR® S&P Biotech ETF. , and Amgen Inc. A few losers won't cause XBI to crash. Both VHT and XBI are ETFs. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. Below is the comparison between IBB and XBI. ARKG is an actively managed Exchange Traded Fund (ETF) that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy, and consumer. •. Total healthcare and life sciences M&A was about $71. 16bn USD. IBB vs. Holdings. The current portfolio value is calculated to be $6. The 10 largest holdings have a combined 17. 54%. 97. It is gross of any fee waivers or expense reimbursements. Share class size. Fidelity does not endorse or adopt their content. Mean reversion is inevitable, and her ARKG fund was up something like 300% in 2020 (it was absolutely killing the market for a few years before then too). Lucy Brewster | Nov 10, 2023. Compare fees, performance, dividend yield, holdings, technical indicators, and many other metrics to make a better investment decision. Across the 192 current stocks in the fund, all holdings have a weighting between 0. SPDR S&P Biotech ETF Stock Up 1. XBI has a beta of 0. Diversification. 81 and $97. 12% in the. Last Price Today's Change Today's Volume : Prospectus. Investo S&P Biotech Sel Industry ETF IE. View complete XLP exchange traded fund holdings for better informed ETF trading. Research performance, expense ratio, holdings, and volatility to see if it's the. The Composition of the XBI is the Key. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. 88%. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (AMEX: XBI) where we have detected an. Site search Search. XBI vs BBH. SPDR S&P Biotech ETF. Better trading starts here. The fund’s NAV was $81. Looking at the chart above, XBI's low point in its 52 week range is $62. Both BBC and XBI are ETFs. Meanwhile, XBI equal weights its holdings. While ETFs offer diversified exposure, which minimizes single stock risk, a deep look into a fund's holdings is a valuable exercise. 96%, and is down about -5. 52%. Neena Mishra May 10, 2023. XBI SPDR S&P Biotech ETF Price: undefined undefined Change: Category: Health & Biotech Equities Last Updated: Nov 21, 2023 Vitals Issuer State Street Brand. Both IBB and XBI have a similar number of assets under management. 17% for the trailing three-year period, which makes XBI a high. Summary. XBI's top 10 holdings account for about 11. XBI, MDGL, SGEN, NTRA: ETF Outflow Alert. XBI is one of a handful of biotech ETFs available, offering exposure to a corner of the market that can perform well during periods of consolidation and is capable of big jumps in the event of major drug approvals. The ETF's holdings are roughly equally weighted, with the biggest positions making up less than 1% of the total fund. XBI has traded between $64. 19%. 003 on 06/20/23 ; Management Fee 0. XBI touched $73. 48%: Number of Holdings 78: Price/Book Ratio Price/Book Ratio. 7% of assets. 2 %. XBI – SPDR® S&P Biotech ETF – Check XBI price, review total assets, see historical growth, and review the analyst rating from Morningstar. 2B Total Assets 0. Performance and Risk. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. While IBB has many more holdings than XBI (376 vs. The equal weight fund, designed to deliver. 94 per share, with $121. Performance and Risk The ETF has lost about -29. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. Taking a look at the XBI, it peaked at $174. Most recent portfolio value is calculated to be $ 7,141,224,184 USD. Assets Under Management. 97. Comparing the most. 1%). Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P. 94 per share, with $121. The top ten holdings have a 48. Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the SPDR S&P Biotech ETF (XBI) is a passively managed exchange traded fund launched on 01/31/2006. Holdings: 266: Inception Date: Feb 5, 2001: About IBB Fund Home Page The iShares Biotechnology ETF (IBB) is an exchange-traded fund that is based on the NYSE Biotechnology index. IBB’s holdings include many leading biotech companies, with holdings capped at 8% on the five largest constituents and 4% for the remaining holdings. Performance and Risk. 4% of the stocks in our database. 94 per share, with $107. S. 23%) Advertisement SPDR S&P Biotech ETF (XBI) NYSEArca - NYSEArca Delayed Price. Implied XBI Analyst Target Price: $135. Get a real-time stock price quote for XBI (SPDR S&P BIOTECH ETF). 50 Bil, only including common equities, preferred equities, ETFs, options and warrants for equities. 77. 65%. 58%: Halozyme Therapeutics Inc:XLY News. In a true biotech bust, where investors can't bear the thought of owning a biotech company ever again, there's little to stop XBI from falling to a near 1 P/B ratio when 80% of its top holdings. 22%: Revolution Medicines Inc Ordinary Shares: RVMD: 1. Mirati. View daily, weekly or monthly format back to when SPDR S&P Biotech ETF stock was issued. 84. IBB’s holdings include many leading biotech companies, with holdings capped at 8% on the five largest constituents and 4% for the remaining holdings. IBB has 8. 08 per unit, that means that analysts see 59. According to 9 analysts, the average rating for IMGN stock is "Strong Buy. Based on its analysis of these factors, SSGA Funds Management, Inc. 50. 2. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P. XBI / SPDR Series Trust - SPDR Biotech ETF short borrow fee rates are shown in the following table. 91 (11/14/23) 1 Day XBI 0. 38%. 22% of total assets) As of November 16, 2023. This type of methodology gives the smaller companies a greater importance in the fund thereby amplifying the gains and losses from small. Both IBB and XBI are ETFs. Both FBT and XBI are ETFs. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. 83%: Other: 0. 1% vs 0. 42 billion worth of. 01%). 70% so far this year and is down about -16. The Health category average is 45. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P— Biotech ETF (Symbol: XBI) where we have detected an. . XBI has traded between $64. 37% in the last one. $0. Holdings; Performance; Risk; Performance Overview-12. 81 and $97. XBI vs ARKG. Performance and Risk The ETF has lost about -3. ETF Channel Staff - Friday, October 20, 6:48 AM. IBB’s holdings include many leading biotech companies, with holdings capped at 8% on the five largest constituents and 4% for the remaining holdings. 79 in February 2021 and has fallen over (50%) to $76. Historical Price Data. SPDR S&P Biotech ETF ETF holdings by MarketWatch. 60 as the 52 week high point — that compares with a last trade of $77. Net expense ratio. 06 as the 52 week high point — that compares with a last trade of $102. Please contact [email protected] XBI trading at a recent price near $81. Learn everything about SPDR S&P Biotech ETF (XBI). 10 as of November 2, 2022. 98 and standard deviation of 40. There is no guarantee the fund will achieve its stated investment objective. 9%: Israel: 3. $156. 8 million shares. XBI, the SPDR S&P Biotech ETF, tracks the performance of the S&P Biotechnology Select Industry Index, offering exposure to the biotechnology sector. With about 156 holdings, it effectively. 78 per share, with $134. Top Ten Holdings as of 10/31/2023 Top 10 Holdings in XBI 16. Elevate your fund analysis with Holdings Data, allowing you to dive deeply into the intricacies of ETFs and Mutual Funds. 7 days ago - Exploring Economic Indicators: Household Debt, Consumer Sentiment, and Trade - ETF Trends 14 days ago - What's Happening in the Labor Market? - ETF Trends ; 21 days ago - GDP Surges as Sentiment Slides: A Week of Economic Insights - ETF Trends 25 days ago - Consumer Discretionary vs. Visitors trend 2W 10W 9M. XBI has traded between $73. 0. Themes & Subsectors ETFs. 8% of its total assets under management. Front end load. 95% for the trailing three-year period, which makes the fund a high risk choice in the space. XBI - SPDR® S&P Biotech ETF - Review the XBI stock price, growth, performance,. 15 billion. The adjacent table shows a Realtime Rating for several different metrics, including liquidity, expenses, performance, volatility, dividend, concentration of holdings in addition to an overall rating. No, even the large cap biotechs get pumped before a final FDA decision on a drug in their pipeline and usually have a sell off after on profit taking or a failed decision. XBI Portfolio - Learn more about the SPDR® S&P Biotech ETF investment portfolio including asset allocation, stock style, stock holdings and more. Veeva Systems. 40. XBI's 120. 64% for the trailing three-year period, making it a high risk. No company usually makes up more than two percent of. VHT has a lower expense ratio than XBI (0. Explore FBT for FREE on ETF Database: Price, Holdings, Charts, Technicals, Fact Sheet, News, and more. So far this year, XBI has lost about -5. N/A. Performance charts for SPDR S&P Biotech ETF (XBI - Type ETF) including intraday, historical and comparison charts, technical analysis and trend lines. Feel free to the browse the list and view the comparisons that are of an interest to you. SPDR SERIES TRUST's SPDR (R) S&P (R) Biotech ETF (XBI) has disclosed 141 total holdings in their latest N-PORT filing with the SEC for the portfolio date of 2023-06-30. If Moderna's share price. 44 per share, with $92. Find SPDR® S&P Biotech ETF (XBI) top 10 holdings and sector breakdown by %. Start Free Trial. Looking at the chart above, XBI's low point in its 52 week range is $62. $7. The firm has a market cap of $5. Staples:. S. Net Expense Ratio. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P. So far this year, XBI has lost about -5. 9. XBI provides a unique investment focus, as its holdings are largely small and mid-cap biotech firms rather than larger pharmaceutical companies such as Pfizer and Johnson & Johnson . 7. Compare ETFs XBI and IBB on performance, AUM, flows, holdings, costs and ESG ratings. VHT vs XBI. All 142 XBI Holdings. S&P Select Industry Indices are designed to measure the performance of narrow GICS® sub-industries. Top 10 Holdings (14. Find Direxion Daily S&P Biotech Bull 3X Shares ETF (LABU) top 10 holdings and sector breakdown by %. Shares Held Weight In Fund. L ooking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR— S&P. The beaten-down prices offer a solid buying opportunity for investors. Trader's Guide 2024 Ships December 21st. Looking at the chart above, XBI's low point in its 52 week range is $62. 53 (3. Market On Millstream The. 96% vs -5. 1. Free commission offer applies to online purchases select ETFs in a Fidelity brokerage account. LABU has a higher expense ratio than XBI (1. The company has an 88. SGEN. 13%) Gold 1,980. More XBI Holdings Current Portfolio Date Nov 20, 2023; Equity Holdings 132; Bond Holdings 0; Other Holdings 3 % Assets in Top 10 Holdings 16. DLTR. The latter proposal about IBB determines its main difference from XBI - the former is more focused on the large biotech companies (the share of Amgen Inc. ARKG is an actively managed Exchange Traded Fund (ETF) that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy, and consumer. The split for XBI took place on September 11, 2015. Holdings; Performance; Risk; Performance Overview-12. The fee is slightly higher for SBIO - . NEW: Experience our best charts yet. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one. 60 as the 52 week high point — that compares with a last trade of $70. 35%). Find SPDR® S&P Biotech ETF (XBI) top 10 holdings and sector breakdown by %. Currency in USD. With XBI trading at a recent price near $131. 2. Free commission offer applies to online purchases select ETFs in a Fidelity brokerage account. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the XBI: SPDR S&P. 2, 2023. 64 per share, with $174. This major support zone runs from $101. It compares fees, performance, dividend yield, holdings, technical indicators, and many other metrics that help make better ETF investing. 80% of total assets under management. 81. XBI (NYSE Ticker) Summary Prospectus-October 31, 2018. View complete XLV exchange traded fund holdings for better informed ETF trading. 1. Holdings. 12% in the last one year (as of 03/16/2023). 58% and is down about -14. Warren Buffett is known for holding onto his S&P 500 stocks forever. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. Performance and Risk The ETF has lost about -29. For an investor to take. With about 151 holdings, it effectively. 36% of total assets under management. Complete SPDR S&P Biotech ETF funds overview by Barron's. Expense ratio and liquidity are average for the group. Seeks to track a modified. N/A. View Top Holdings and Key Holding Information for VanEck Gold Miners ETF (GDX). 10 as of November 2, 2022. XBI has lost 27. The vast majority of XBI holdings have less. 27. SPDR® S&P Biotech ETF XBI. 1% which highlights the scope of the fund and diversification away from company-specific risks. During this past 52-week period, the fund has traded between. 2013. 12% in the last one year (as. The ETF's holdings are roughly equally weighted, with the biggest positions making up less than 1% of the total fund. 19%. Themes & Subsectors ETFs. 60 as the 52 week high point — that compares with a last trade of $69. This large ETF has performed well and is at its year highs, but will it continue to outperform? With takeover activity occurring in the sector, how will this ETF benefit? How is this ETF. 87. Search or filter ETFs by fund name, ticker, ISIN, or CUSIP, and browse for SPDR ETFs that align with your investment objectives. We have highlighted five ETFs from different. Looking at the chart above, XBI's low point in its 52 week range is $62. That's the main advantage to investing. 12 and $91. In addition, the recent spike in volatility has increased option prices even. So far this year, XBI has lost about -5. Rated on Jun 30, 2023 Published on Jun 30. Find iShares Core High Dividend ETF (HDV) top 10 holdings and sector breakdown by %. 09%: Canada: 1. It's trading down (17%) versus LABU, down (68%) in one-year performance. Price Chart. Top 10 Holdings (14. 27%. Aug 4, 2021 10:47AM EDT. XBI: SPDR® S&P Biotech ETF: 1. The fund has a beta of 0. 🇺🇸. While this ETF allocates. Top 10 Holdings. ETFs - IBB, PBE, XBI. 01%). 16bn USD. 39. TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks. Message board - Online Community of active, educated investors researching and discussing Novavax Inc. 5. 01 %IBB: iShares Biotechnology ETF: 0. argenx SE ADR. 7 days ago - Exploring Economic Indicators: Household Debt, Consumer Sentiment, and Trade - ETF Trends 14 days ago - What's Happening in the Labor Market? - ETF Trends ; 21 days ago - GDP Surges as Sentiment Slides: A Week of Economic Insights - ETF Trends 25 days ago - Consumer Discretionary vs. 71% of total assets under management. XBI, BEAM, FATE, NTLA: ETF Outflow Alert. Find the latest SPDR® S&P Biotech ETF (XBI) stock analysis from Seeking Alpha’s top analysts: exclusive research and insights from bulls and bears. VHT has a lower expense ratio than XBI (0. Company Change % Net. 4; Top 10 Holdings % Portfolio Weight Market Value USD 2014. 02%. Currency in USD Follow 2W 10W 9M 72. 86% so far this year and is down about -32. BTEK11. The ETF return is roughly 4. XBI, HZNP, BIIB, VCYT: ETF Outflow Alert. That's the main advantage to investing. 20. Launched on 01/31/2006, the SPDR S&P Biotech ETF (XBI) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare . XBI's top 10 holdings account for about 14. 15%: Country Percentage; United States: 94. Find the latest SPDR S&P Biotech ETF (XBI) stock quote, history, news and other vital information to help you with your stock trading and investing. 75. At midday the XBI is rebounding indicating there is buying interest near $101. total market composite index. XBI Description. com) ReturnsXBI's top 10 holdings account for about 10. 0. Performance. The following charts reflect the geographic spread of WCLD's underlying holdings. 50 down to $98. 1. 95. WisdomTree Cloud Computing Fund ETF holdings by MarketWatch. Elevate your fund analysis with Holdings Data, allowing you to dive deeply into the intricacies of ETFs and Mutual Funds. IBB vs. 61%) 13,857,540 Average : As of close 11/17/2023: Summary; News; Charts;. The actual earnings estimates for the underlying holdings are provided by FactSet, First Call, I/B/E/S Consensus, and Reuters and are used to calculate a mean 3-5 year EPS growth rate estimate. 85. Holdings; Performance; Risk; Advertisement. Jun 23, 2022 10:49AM EDT. 35%. 79 as the 52 week high point — that compares with a last trade of $159. 46% YTD Daily Total ReturnETF Summary. Check out the side-by-side comparison table of XBI vs. View complete WCLD exchange traded fund holdings for better informed ETF trading. February 15, 2023 — 10:47 am EST. The XBI has been a leader beating other ETFs YTD, up about 35% until today. Shares of Amgen , IBB's top holding with a weight of 8. 58%: Halozyme Therapeutics Inc:How To Invest / Fund Directory / ARK Genomic Revolution ETF vs SPDR S&P Biotech ETF . Below is the comparison between FBT and XBI. Netherlands. Neena Mishra May 10, 2023. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the SPDR S&P. XBI, whose index recently expanded, also owns only a handful of established biotech companies. XBI holdings. 7. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P. The most heavily invested institutionals were Morgan Stanley ($614. Other fees such as trading (non-commission) fees, Gold subscription fees, wire transfer fees, and paper statement fees may apply. " The 12-month stock price forecast is $22. Published. News & World Report, XBI enjoys volume of 20. 49. In addition to holding 155 positions, its top 10. Again, top 10 holdings. 07. As a result, the ETF reached a new 8-month low. $72. 35% for XBI, but SBIO yields 2. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. Elevate your fund analysis with Holdings Data, allowing you to dive deeply into the intricacies of ETFs and Mutual Funds. Top Holdings . 35% Expense Ratio 20 40 60 per page Viewing 1-20 of 134 matches 1 2 3 4 5 XBI: SPDR S&P Biotech ETF - Fund Holdings. Summary From a population of some 350 actively-traded, substantial, and growing ETFs this is a currently attractive addition to a portfolio whose principal objective is wealth accumulation by active investing. Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an. XBI - SPDR (R) S&P (R) Biotech ETFs top. XLV comparisons: including fees, performance, dividend yield, holdings and technical indicators to make a better investment decision. *Close price adjusted for splits. S. Holdings Details. This is the case with most of XBI's holdings which do not yet have products at commercialization stage, except for notable exceptions including Moderna (NASDAQ: MRNA) and Regeneron (NASDAQ: REGN). Also I like this style of etf from power shares because the holdings are less weighted in the top two powerhouses (Amgen and Gilead for PJP) than "traditional" ETF's. 1. Below is the comparison between LABU and XBI. The index and exchange-traded fund ETF are rebalanced four times a year. Its price to cash flow multiples is about 13. The big biotech. Asset type; Sector; Region; Asset type. Nov 20, 2023Top 10 Holdings. However, XBI has a built-in advantage that was mentioned earlier: It owns stocks in relatively equal weights. 88%. We have highlighted five ETFs from different. Holdings.